The effects on clinical outcomes of administering medications together or separately in prolonged dual antiplatelet therapy after peripheral revascularisation
ASA doses of 75 mg or 81 mg did not affect one-year patency rates. However, higher bleeding rates were observed in the group that received both clopidogrel and ASA treatment simultaneously (in the morning) despite the lower dose of ASA.
Authors
- Oğuz Karahan (ORCID: https://orcid.org/0000-0003-0044-9476)
- Özgür Akkaya (ORCID: https://orcid.org/0000-0001-6460-5066)
Institutions
- Alanya University (TR)
- Alanya Alaaddin Keykubat Üniversitesi (TR)
Publication Details
- Journal
- Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa
- Published
- 2024-09-01
- DOI
- https://doi.org/10.5830/cvja-2023-013
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00